GlassScriptPhysician profile
Hua Shan
NPI 1679502058
$295,294.65
in general payments reported to CMS, 2019-2025
5 companies · $57K in 2025
The $57K reported for 2025 was more than what 98% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $5,781 · 2021: $18K · 2022: $39K · 2023: $90K · 2024: $53K · 2025: $57K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $180K · Travel and Lodging: $17K · Food and Beverage: $1,550 · Gift: $44.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $180,319.68 |
| Travel and Lodging | $17,398.97 |
| Food and Beverage | $1,549.53 |
| Gift | $44.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerus Corporation | $288,581.08 | 2019-2025 | Intercept Blood System For Platelets, Intercept Blood System For Cryoprecipitation |
| Terumo Bct, INC. | $5,550.00 | 2019 | |
| Grifols Diagnostic Solutions, INC. | $1,032.43 | 2019-2021 | |
| Genzyme Corporation | $75.17 | 2019 | |
| Abbott Laboratories | $55.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hua Shan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.